Researchers at the Centre for Study and treatment of circadian rythms.

Through research at PEPP, patients benefit from new knowledge, resulting in state-of-the-art diagnostic and treatment methods for the early stages of psychosis

The research team led by Serge Beaulieu, MD, PhD, FRCPC is interested in the biological and environmental factors of bipolar disorders.

2009 Prix Coup de cœur de l'Association québécoise d'établissements de santé et services sociaux (AQESSS) Special Jury Award in recognition of its public education program Communications

The basic and clinical research is oriented towards the long-term consequences for the brain of early perinatal and neonatal exposure to stressors.

A multidisciplinary team Ashok Malla, MD, FRCPC, psychiatrist, director, PEPP-Montréal Ridha Joober, MD, PhD, psychiatrist, assistant director, PEPP-Montréal Evangeline Smith, clinical-administrative chief, PEPP-Montréal

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Psychotic Disorders Program at the Douglas Institute provides services to adults aged 18 to 65 with schizophrenia or other forms of psychoses, with the exception of the Prevention and Early Intervention Program for Psychoses (PEPP-Montréal), which is designed for people aged 14 to 30.

The Depressive and Suicide Disorders Program is a superspecialized (third-line) service for youth and adults who suffer from refractory and/or recurrent major depressive disorder with or without the presence of suicidal behaviour. The program offers cutting-edge treatment for clients and provides support to families to help them interact with the person in difficulty.

The Bipolar Disorders Program is a superspecialized (third-line) consultation and treatment service for adults aged 18 to 65 who suffer from refractory bipolar disorders.